Matching-Adjusted Indirect Treatment Comparison of Sotorasib vs Adagrasib for Previously Treated Non-Small Cell Lung Cancer with KRAS G12C Mutation (20240246)

Study type

• Study topic:
  Disease /health condition

  Human medicinal product
• Study type:
  Clinical trial
• Scope of the study:
  Safety study (incl. comparative)

Study drug and medical condition

• Study drug International non-proprietary name (INN) or common name:
  SOTORASIB

  ADAGRASIB
• Anatomical Therapeutic Chemical (ATC) code:
  (L01XX73) sotorasib

  sotorasib

  (L01XX77) adagrasib

  adagrasib
• Medical condition to be studied:
  Non-small cell lung cancer recurrent